Immunomodulatory activity of exopolysaccharide from the rhizobacterium Paenibacillus polymyxa CCM 1465

Irina V Yegorenkova1, Alla A Fomina2, Kristina V Tregubova3

  • 1Institute of Biochemistry and Physiology of Plants and Microorganisms, Russian Academy of Sciences (IBPPM RAS), 13 Prospekt Entuziastov, Saratov, 410049, Russian Federation. egorenkova_i@ibppm.ru.

Archives of Microbiology
|August 30, 2018
PubMed

Insights

Exopolysaccharide from Paenibacillus polymyxa CCM 1465 enhances nonspecific immunity by boosting immune cell activity. This bacterial polysaccharide shows potential as an immunomodulatory substance for promoting health.

Area of Science:

  • Immunology
  • Microbiology
  • Biochemistry

Background:

  • Bacterial polysaccharides are recognized for their potential to stimulate protective immune responses in hosts.
  • The exopolysaccharide (EPS) produced by Paenibacillus polymyxa CCM 1465 is a candidate for inducing nonspecific resistance.
  • Understanding the immunomodulatory effects of bacterial EPS is crucial for developing novel therapeutic agents.

Purpose of the Study:

  • To investigate the immunomodulatory potential of exopolysaccharide from Paenibacillus polymyxa CCM 1465.
  • To evaluate the effect of EPS produced using different carbon sources on various immune cell functions.
  • To determine the capacity of EPS to induce nonspecific resistance factors in a macroorganism.

Main Methods:

  • In vitro analysis of murine macrophage phagocytic activity.
  • Assessment of reactive oxygen species and enzyme generation (acid phosphatase, myeloperoxidase) in leukocytes.
  • Measurement of murine splenocyte proliferation.
  • Quantification of proinflammatory cytokine synthesis (IL-1β, TNF-α) by human mononuclear cells.

Main Results:

  • The exopolysaccharide significantly promoted phagocytosis of bacterial cells by macrophages.
  • Metabolic activity in human and animal leukocytes was enhanced by the exopolysaccharide.
  • Moderate effects were observed on the production of tumor necrosis factor α (TNF-α) and interleukin-1β (IL-1β).
  • Differences in immune cell responses were noted between exopolysaccharides produced on glucose versus sucrose media, suggesting variations in composition and structure.

Conclusions:

  • Exopolysaccharide from Paenibacillus polymyxa CCM 1465 effectively promotes nonspecific immunity.
  • The EPS demonstrates potential as a biologically active immunomodulatory substance.
  • Variations in carbon sources during production can influence the immunomodulatory properties of the EPS.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
542
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.0K
Activation Energy01:26

Activation Energy

Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
86.7K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.8K
Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
138.0K